Companies / TScan Therapeutics
TScan Therapeutics
Waltham, United States
TScan Therapeutics is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor-engineered T cell therapies for the treatment of patients with cancer.
TScan Therapeutics, based in Waltham, United States, has 4 investors on file, among them Astellas Venture Management, Bessemer Venture Partners and Pitango. Its site was last checked 6 Nov 2026: site answers.
SEC Form D filings
2 filingsFiled by TScan Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
1 headline naming TScan TherapeuticsEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get TScan Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Astellas Venture Management adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/tscan.com/investors
# also
GET /v1/companies/tscan.com
GET /v1/companies/tscan.com/news